![]() Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Rubinshtein R, Glockner JF, Ommen SR, et al. Long-Long-term outcome in patients with apical hypertrophic cardiomyopathy. Am J Cardiol 1979 44: 401-412.Įriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H. Ventriculographic and echocardiographic features in 30 patients. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy). Echocardiographic and ultrasono-cardiotomographic study. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. The clinical applications of contrast echocardiography. Olszewski R, Timperley J, Szmigielski C, Monaghan M,Nihoyannopoulos P, Senior R, et al. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich AG, Maron BJ. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. Germans T, Wilde AA, Dijkmans PA, ChaiW, Kamp O, Pinto YM, van Rossum AC. Long-term outcome in patients with apical hypertrophic cardiomyopathy. European Heart Journal 2014 35: 2.733-2.779.Įriksson MJ, Sonnenberg B, Woo A, et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2008 29: 270-276.Įlliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron PH, et al. Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. J Am Coll Cardiol 2011 58: 839-848.Įlliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofi lament gene mutations. Olivotto I, Girolami F, Sciagra R, Ackerman MJ, Sotgia B, Bos JM, et al. ![]() Implantable cardioverter-defi brillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Coronary Artery Risk Development in (Young) Adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |